If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2007 Ph.D., National Taiwan University Pathology 
  • 1998 MS, National Taiwan University  Pathology  
  • 1996 BS.. China Medical University   Medical Technology   

Experience

  • 2013- School of Medical Laboratory Science and Biotechnology Assistant Professor
  • 2009 Seattle Childrens Research Institute fellow Ph.D
  • 2007 Department of medical Laboratory Science and Biotechnology fellow Ph.D.

Awards

  • 2011 53rd ASH abstract achievement awards- American Society of Hematology
  • 2013 55rd ASH abstract achievement awards- American Society of Hematology
  • 2013-2015 NSC University outstanding investigator recruitment award
  • 2016 Excellent research paper award-Teachers and students joint academic research symposium (TMU)

Research Interests

  • Immunotherapy

Fingerprint Dive into the research topics where Chao-Lien Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Factor VIII Medicine & Life Sciences
Hemophilia A Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cells Chemical Compounds
Cell growth Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2020

嵌合抗原受體T細胞用於治療人類卵巢癌的免疫療法(1/3)

Liu, C.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

劉兆蓮-107研究計畫績效獎

Liu, C.

8/1/187/31/20

Project: B - Project of TMUh - Other (Funded by TMU)

建構抗免疫監測點抑制因子PD1 與PDL1的嵌合抗原受體T 細胞來治療胰臟癌(3/3)

Liu, C.

8/1/187/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

建構抗免疫監測點抑制因子PD1 與PDL1的嵌合抗原受體T 細胞來治療胰臟癌(2/3)

Liu, C.

8/1/177/31/18

Project: A - Government Institutionb - Ministry of Science and Technology

抗免疫監測點抑制因子PD1 與PDL1的嵌合抗原受體修飾性γδ-T細胞用於治療卵巢癌療效之探討

Liu, C.

7/1/172/28/18

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 2002 2019

  • 189 Citations
  • 7 h-Index
  • 13 Article

Ex vivo expanded human Vγ9vδ2 T-cells can suppress epithelial ovarian cancer cell growth

Mao, T. L., Miao, C. H., Liao, Y. J., Chen, Y. J., Yeh, C. Y. & Liu, C. L., Mar 1 2019, In : International Journal of Molecular Sciences. 20, 5, 1139.

Research output: Contribution to journalArticle

Open Access
T-cells
Cell growth
cancer
Tumors
T-Lymphocytes

SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma

Liu, C. L., Pan, H. W., Torng, P. L., Fan, M. H. & Mao, T. L., Jan 1 2019, In : Oncology Reports. 42, 6, p. 2706-2715 10 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Fibroblasts
Carcinoma
Proteins
Neoplasms

Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma

Suk, F. M., Liu, C. L., Hsu, M. H., Chuang, Y. T., Wang, J. P. & Liao, Y. J., Dec 1 2019, In : Scientific Reports. 9, 1, 17259.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Therapeutics
Epithelial-Mesenchymal Transition
Heterografts
Glypicans
14 Citations (Scopus)

Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer

Mao, T. L., Fan, K. F. & Liu, C. L., Oct 1 2017, In : Gene Therapy. 24, 10, p. 621-629 9 p.

Research output: Contribution to journalArticle

Carcinoma
Ovarian Neoplasms
Cell Movement
Neoplasms
CXCR4 Receptors